
AI, Longevity, and the Future of Healthcare, with Dr. Eric Topol
Cardiologist and genomics researcher Dr. Eric Topol of the Scripps Research Translational Institute joins Stanford hosts Justin Norden and Matthew Lungren for the fourth installment of Stanford Online's AI in Medicine series. Topol discusses how artificial intelligence could reshape disease prevention, drug discovery, and the study of aging, drawing on his work in precision medicine and genomics. The conversation covers AI's potential for early detection of age-related disease, individualized longevity strategies, and more patient-centered models of care, alongside a frank look at where current healthcare systems fall short. Framed as a discussion rather than a formal lecture, it moves between Topol's research background and the hosts' questions about medical education and clinical practice. The result is a grounded survey of where AI in medicine stands and what Topol sees as its realistic near-term applications, rather than a speculative sales pitch for the technology.